The global theranostics market reached USD 1.8 billion in 2022 and is projected to grow to USD 4.2 billion by 2031, exhibiting a CAGR of 11.3% during the forecast period 2024–2031, driven by rising demand for personalized and precise medical treatments. Theranostics combines diagnostics and targeted therapy to tailor care based on individual disease profiles, leveraging molecular and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek